BioCentury
ARTICLE | Company News

Optimer, Memorial Sloan-Kettering Cancer Center deal

October 7, 2002 7:00 AM UTC

Optimer received an exclusive global license for Globo H vaccine from the center to treat breast and prostate cancer. Optimer will oversee marketing of the vaccine, which is in clinical development. O...